A third platform for ordering cannabis in Ontario provides little to no benefit to consumers or retailers.
Articles on Cannabis
Displaying 81 - 100 of 316 articles
Provincial governments should follow the federal government’s lead by revisiting their cannabis policies to improve them.
Research has long shown that criminalising otherwise law-abiding citizens for their drug use is no deterrent. It only damages their life chances, in a discriminatory fashion.
Health repercussions — including large increases in child cannabis poisonings — must outweigh industry calls to roll back cannabis regulations in the federal review of the impact of legalization.
Cannabis consumption erodes mental well-being and has adverse effects on school, work, and social life.
People in Nigeria are creating new drugs either because they can’t afford more traditional narcotics, because they’re not controlled or because they’re strong.
Drug use among young people continues to fall, but harmful use among a minority continues.
With the dual threats of antibiotic resistance and emerging pandemics, finding new drugs becomes even more urgent. A trove of medicines may be lying under our nose.
In the mid-1800s, France was at the epicenter of the international movement to medicalize hashish, a potent form of cannabis. Now the country’s medical marijuana research is making a comeback.
France may be getting closer to legalizing cannabis. Still, arrests are rising quickly and often target Arab Muslim men.
Holiday destinations are creating cannabis-related events and activities to capture a new travel trend.
Medicinal cannabis products were made legal in New Zealand in 2020. But high costs and widespread reluctance from doctors means many sick people are still accessing cannabis illegally.
Ensuring the participation of ordinary citizens and producers in the industry is the big challenge facing African states.
Does the success of this single issue minor party mean that Australians are finally ready to ‘legalise it’?
Policy-makers and stakeholders in Canada should re-examine CBD policies and ensure they are protecting, rather than confusing, consumers.
Canada is in a position to be a global leader in setting an international precedent for socially responsible and informed policy for cannabis.
Scholars weigh in on the known and unknown about marijuana and its incarnations.
Cannabis use is linked to poorer memory, attention and mental health.
While the pandemic was often blamed for 2020-2021’s strong recreational cannabis sales growth, the boost in sales was more likely due to existing trends, added stores and new products.
Growing interest in psychedelics has spurred new research decades after hallucinogenics were tested in Saskatchewan in the 1950s. And an unassuming common fish is proving a useful test subject.
Top contributors
-
Professor of Operations Research, Brock University
-
Honorary Fellow, Department of Health Sciences, University of York
-
Adjunct Professor at the National Drug Research Institute (Melbourne based), Curtin University
-
Lecturer, RMIT University
-
Professor in Criminology, Loughborough University
-
Emeritus Professor, National Centre for Youth Substance Use Research, The University of Queensland
-
Professor of History, University of Johannesburg
-
Professor in Substance Use, Liverpool John Moores University
-
Associate Professor of Public Policy and Administration, Penn State
-
Research Scientist, BC Centre on Substance Use and Assistant Professor in the Division of AIDS, Department of Medicine, University of British Columbia
-
Assistant Professor of History, Bard Early College
-
Emeritus Consultant, St Vincent's Hospital, Darlinghurst
-
Assistant Professor of Psychiatry and Behavioral Neurosciences, Wayne State University
-
PhD student in Population and Public Health, University of British Columbia
-
Public Health Physician and Canada Research Chair and the University of Ottawa, L’Université d’Ottawa/University of Ottawa